| Neuroprotective Therapy Using Granulocyte-Colony Stimulating Factor for Patients With Worsening Symptoms of Thoracic Myelopathy: A Multicenter Prospective Controlled Trial. | |
| | |
MedLine Citation:
|
PMID: 22652593 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
ABSTRACT: Study Design. An open-labeled multicenter prospective controlled clinical trial.Objective. To confirm the feasibility of granulocyte colony-stimulating factor (G-CSF) administration for patients with thoracic myelopathy.Summary of Background Data. Although G-CSF is best known as an important cytokine commonly used to treat neutropenia, it also has non-hematopoietic functions. Previous experimental studies have shown that G-CSF can enhance tissue regeneration of several organs, such as the heart and brain. We previously reported that G-CSF promotes functional recovery after spinal cord injury in rodents. Based on those findings, we started a clinical trial of neuroprotective therapy using G-CSF for patients with worsening symptoms of thoracic myelopathy.Methods. Patients whose Japanese Orthopaedic Association (JOA) score for thoracic myelopathy had decreased two points or more during a recent one-month period were eligible for entry. After giving informed consent, patients were assigned to G-CSF and control groups. The G-CSF group (n = 10) received G-CSF 10 μg/kg/day intravenously for five consecutive days. The control group (n = 14) received similar treatments as the G-CSF group except for G-CSF administration. The primary outcome was JOA recovery rate at one month after G-CSF administration or initial treatment.Results. There was greater improvement in neurologic functioning between baseline and one month follow-up in the G-CSF group (JOA recovery rate: 29.1 ± 20.5%) compared with the control group (JOA recovery rate: 1.1 ± 4.2%) (P < 0.01). No serious adverse events occurred during or after the G-CSF administration.Conclusion. The results provide evidence that G-CSF administration caused neurological recovery in patients with worsening symptoms of thoracic compression myelopathy. |
| | |
Authors:
|
Tsuyoshi Sakuma; Masashi Yamazaki; Akihiko Okawa; Hiroshi Takahashi; Kei Kato; Mitsuhiro Hashimoto; Koichi Hayashi; Takeo Furuya; Takayuki Fujiyoshi; Junko Kawabe; Chikato Mannoji; Tomohiro Miyashita; Ryo Kadota; Yukio Someya; Osamu Ikeda; Tomonori Yamauchi; Masayuki Hashimoto; Toshimi Aizawa; Atsushi Ono; Shiro Imagama; Tokumi Kanemura; Hideki Hanaoka; Kazuhisa Takahashi; Masao Koda |
Related Documents
:
|
18710443 - Holmium laser prostatic resection for patients presenting with acute urinary retention. 18384853 - Return to continence after radical retropubic prostatectomy: a randomized trial of verb... 19345783 - Pediatric stroke recovery: a descriptive analysis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-5-30 |
Journal Detail:
|
Title: Spine Volume: - ISSN: 1528-1159 ISO Abbreviation: - Publication Date: 2012 May |
Date Detail:
|
Created Date: 2012-6-1 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7610646 Medline TA: Spine (Phila Pa 1976) Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Spine Section, Department of Orthopaedic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan, *Department of Orthopaedic Surgery, Tohoku University School of Medicine † Department of Orthopaedic Surgery, Hirosaki University Graduate School of Medicine ‡ Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine § Spine Center, Konan Kosei Hospital ¶ Department of Clinical Research, Chiba University Hospital. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Autophagic cell death exists.
Next Document: Differences Between TNF-alpha Receptors Type 1 and Type 2 in the Modulation of Spinal Glial Cell Act...